Treasury 0 625% Idx Lkd Gilt 22/11/42 null (GB00B3MYD345) News

Still a low float play right now and this can move fast...

This might be huge:



AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis

Source: GlobeNewswire Inc.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States P

Just reposted what is written. Nothing spam

Nrdc , https://www.stephanoslack.com/our-locations/ , TOP 400 !

Grace period removed

Authorized Shares
4,000,000,000
10/04/2024
Outstanding Shares
1,695,351,226
10/04/2024
Restricted
74,354,014
10/04/2024
Unrestricted
1,620,997,212
10/04/2024

Merely posting to it claims otherwise. 💯

https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Ftse3.mm.bing.net%2Fth%3Fid%3DOIP.-jseX4ZFekvcykhxHgEQFQHaF7%26pid%3DApi&f=1&ipt=2c05f1904adf00fc98e19ab21563b84761d4f4ac91d216a791c3d47999fa2bb4&ipo=images

Who

UBA

In early 2019 it became impossible to AIM my UBA, from 2010 it was AIMed and from 2019 B&H.
I haved waited 5 years, but rules and regulations did no

Thanks for the spam, but this is probably the wrong MB on which to pimp a stock, even if it has just been awarded a (relatively meaningless) method patent.

The words I like the most ( you have to take good care of shareholders) with that attitude were golden. Thanks for sharing

I've been keeping a close eye on Realbotix ($XBOT)! They were recently featured on FOX News, but somehow they're still flying under the radar. They're developing advanced humanoid robots with AI that could change how we interact with technology forever. Their robots show serious potential, especiall

We now have confirmation that no one can point to a single positive prediction about VPLM made by DeerBalls that actually came to pass.

Hence the flood of dissembling and diversion from the actual question.

I guess a really crappy scam stock like VPLM deserves the barre

RESEARCH & DEVELOPMENT IS BEING PERFORMED CONTINUOUSLY BY MANY

COMPANIES IN THE SECTOR...

UP TO THIS POINT IN TIME (SINCE KBLB'S INCEPTION), THAT"S ALL KBLB CAN BOAST OF

ALLEGEDLY "DOING."

ANYONE CAN SIGN A POTENTIAL CONTRACT AND FAIL T

Thanks for that. I just started

following CUE. Love their biz, plus 21% of the OS are held by institutions. They are still losing $$ and I'm not so sure how much this will run.

Would be nice. See what next week brings.

Not even Elon Musk could afford

to buy on every dip with this company. It is one nonstop long dip.

This might be huge:



AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis

Source: GlobeNewswire Inc.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States Pat

Good for Nvidia

Data center finance leases
Buried within the footnote of its quarterly and annual reports, Microsoft lists the number of finance leases, mostly for data centers, that have yet to commence. The details include the amount of money it has contracted out for leases

I'm hoping that you are correct.


- Has the company even applied for it?
- Why is the company so dull and not enthusiastically touting their accomplishments?
- Their website sucks and is outdated by a few years.
- We do not hear a word from them on anyth

lj: Florida weather
Thanks for the weather forecast video. A neighbor just cancelled her planned trip to Florida next week to visit her elderly mother.

lj: re: interest rates
I think we are in a mild recession. When you don't see many cars at fast-food drive throughs, something is going on.
Egg prices are ridiculous. Eggs are in many food products. IMO, a big part of food inflation.

In Mexico, ‘It’s Time for Women’

"Who is Claudia Sheinbaum? Here’s what to know about Mexico’s next president"

Claudia Sheinbaum took office on Tuesday as the country’s first female president.

By Catherine Osborn, the writer of Foreign Policy’s weekly Lat

lj: Agree about the tax-loss selling this year. Not much out there to push up the market.
The election is a factor that should keep the market down for a month.

https://www.gq.com/story/californias-vanishing-hippie-utopias

😂😂😂😂🤡

If merck want nwbo they still have time to make a purchase. They (MRK)may not think the market for gbm (dcvax plus keytruda) is large enough for them in terms of revenue especially until approved by fda. Should we get approval by MHRA merck may take an interest as then better chance for fda/usa appr